2016 American Transplant Congress
Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
Background;Renal transplantation is the treatment of choice for individuals with end stage renal disease (ESRD).Method; This is a retrospective review of eight live related renal…2016 American Transplant Congress
One-Year Graft Loss Risk in Kidney Transplants – A Big Data Approach.
MUSC, Charleston, SC; IBM Corp., Armonk.
Background Predictive models using national data are limited by lack of evolving patient level data. A Big Data approach using both static and dynamic variables…2016 American Transplant Congress
Renal Transplant in Obese Recipients: Consideration of Donor and Recipient Factors Can Improve Outcomes.
Division of Transplantation, University of Wisconsin-Madison, Madison, WI.
Background: Obesity rates in the transplant population are increasing. Previous studies are limited by small sample sizes, short-term follow up, and conflicting results. Factors including…2016 American Transplant Congress
Factors Associated with Prolonged Warm Ischemia Time Among Deceased Donor Kidney Transplant Recipients.
Prolonged warm ischemia time (the time from organ removal from cold storage to reperfusion with warm blood) is associated with graft failure and mortality among…2016 American Transplant Congress
Differential Effect of Delayed Graft Function (DGF) on Kidney Transplant Outcomes: When Does DGF Not Make a Difference?
Delayed graft function (DGF), defined as need for dialysis in 1st week following kidney transplant (KT), is an early surrogate marker of organ quality and…2016 American Transplant Congress
Enhanced Recovery After Kidney Transplantation: 48 Hour Length of Stay in Living and Deceased Donor Transplant Recipients.
BACKGROUND: Enhanced recovery after kidney transplantation is a desired outcome with potential value-enhancing benefits of reduced length of stay (LOS), costs, and risk of nosocomial…2016 American Transplant Congress
Outcomes of Depleting Antibody Induction in Kidney Transplantation: A Paired Kidney Analysis.
Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA.
Induction therapy can improve graft survival following kidney transplantation. Organ quality, a major determinant of graft outcomes may act as a confounder in comparative studies…2015 American Transplant Congress
Differential Role of PI3K Subunits Gamma and Delta in Regulatory T Cells Homeostasis in Allotransplantation
Renal/Transplant Research Center, Brigham and Women's Hospital, Boston, MA.
Targeting survival pathways that differentially suppress effector T cells (Teff) while sparing regulatory T cells (Tregs) is key in devising novel tolerogenic protocols in transplantation.…2015 American Transplant Congress
Changes in Utilization, Discard, and Outcomes Associated With Hepatitis C (+) Donor Livers in the Era of Direct Acting Anti-Retroviral Therapy
Johns Hopkins University, Baltimore, MD.
While 45% of liver candidates are hepatitis C (HCV) (+) and might benefit from an HCV (+) donor liver, only 7.1% receive one, and HCV…2015 American Transplant Congress
Post-Transplant Lymphoproliferative Disorders Following Alemtuzumab Induction in Kidney Transplantation
Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, England, United Kingdom.
Post-Transplant Lymphoproliferative Disorder (PLTD) is a well-recognised serious complication in renal transplant recipients. Induction with lymphocyte depleting agents such as thymoglobulin has been associated with…
- « Previous Page
- 1
- …
- 98
- 99
- 100
- 101
- 102
- …
- 113
- Next Page »